In contrast, the oncology drug (ONCD) library, screened when enough surgical material was available (n = 12), included cancer therapies such as cyclin-dependent kinase (CDK) and receptor tyrosine kinase (RTK) inhibitors (n = 65 drugs; 10 μM). Here, NTRK1 is linked to cancer.